Clinical value of macrogenome next-generation sequencing on infections

被引:0
|
作者
Han, Benfa [1 ]
Zhang, Xiaoli [1 ]
Li, Xiuxi [1 ]
Chen, Mei [1 ]
Ma, Yanlin [2 ]
Zhang, Yunxia [1 ]
Huo, Song [1 ]
机构
[1] First Peoples Hosp HongHe State, Southern Cent Hosp Yunnan Prov, Dept Infect Dis, Honghe 661000, Yunnan, Peoples R China
[2] Southern Cent Hosp Yunnan Prov, First Peoples Hosp HongHe State, Dept Pharmaceut, Honghe 661000, Yunnan, Peoples R China
来源
OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期
关键词
intracranial infection; pathogen detection; mNGS technology; clinical analysis; efficacy evaluation; DIAGNOSIS; DNA;
D O I
10.1515/biol-2022-0938
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intracranial infection (ICI) is a frequent and serious complication after neurosurgery. Macrogenome next-generation sequencing (mNGS) technology can provide reference for clinical diagnosis and treatment of ICI. This work aimed to explore the application value of mNGS technology in analyzing the clinical characteristics of human immunodeficiency virus (HIV) infection and ICI after neurosurgery. A total of 60 patients with ICI were enrolled as the research objects, all patients underwent routine cerebrospinal fluid analysis and traditional pathogen detection, followed by mNGS genome analysis. Using clinical diagnosis of ICI as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value for both detection methods were calculated. Receiver operating characteristic curves were constructed to assess the area under the curve (AUC) for evaluating the clinical value of mNGS in suspected intracranial infectious pathogen diagnosis. Results showed a positivity rate of 71.67% (43 cases) with mNGS compared to 28.33% (17 cases) with traditional pathogen detection methods, demonstrating a significant difference (P < 0.05). The sensitivity of mNGS for detecting ICIs was 83.7%, significantly higher than the 34.88% observed with traditional methods (P < 0.05). The pathogen detection rate of mNGS was higher than traditional methods (P = 0.002), with an AUC of 0.856 (95% CI: 0.638-0.967), significantly greater than the AUC of 0.572 (95% CI: 0.350-0.792) for traditional methods (P < 0.05). mNGS successfully identified microorganisms such as Cryptococcus, Propionibacterium, Staphylococcus, Corynebacterium, Micrococcus, and Candida associated with ICIs. These findings underscore the clinical applicability of mNGS technology in analyzing the characteristics of HIV infection and ICI post-neurosurgical procedures. This technology enables more accurate diagnosis and treatment of ICIs, providing valuable insights for developing effective therapeutic strategies. Graphical abstract
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Next-generation sequencing and its clinical application
    Dahui Qin
    Cancer Biology & Medicine, 2019, 16 (01) : 4 - 10
  • [42] Next-Generation Sequencing in Diagnostics and Clinical Research
    Hoefler, Gerald
    PATHOBIOLOGY, 2017, 84 (06) : 289 - 291
  • [43] The diagnostic value of next-generation sequencing technology in sepsis
    Cao, Xiao-guang
    Zhou, Shu-sheng
    Wang, Chun-yan
    Jin, Kui
    Meng, Hua-dong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [44] Value of next-generation sequencing in inherited arrhythmia syndromes
    Min Jae Kim
    You Ri Kim
    Ki Hong Lee
    Namsik Yoon
    Hyung Wook Park
    International Journal of Arrhythmia, 24 (1)
  • [45] Diagnostic value of targeted next-generation sequencing in craniosynostosis
    Olech, E. M.
    Sowinska-Seidler, A.
    Popiel, D.
    Koczyk, G.
    Socha, M.
    Walczak-Sztulpa, J.
    Materna-Kiryluk, A.
    Latos-Bielenska, A.
    Posmyk, R.
    Smigiel, R.
    Dawidziuk, A.
    Jamsheer, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1275 - 1276
  • [46] Next-generation sequencing for next-generation breeding, and more
    Tsai, Chung-Jui
    NEW PHYTOLOGIST, 2013, 198 (03) : 635 - 637
  • [47] Next-Generation Sequencing: Next-Generation Quality in Pediatrics
    Wortmann, Saskia B.
    Spenger, Johannes
    Preisel, Martin
    Koch, Johannes
    Rauscher, Christian
    Bader, Ingrid
    Mayr, Johannes A.
    Sperl, Wolfgang
    PADIATRIE UND PADOLOGIE, 2018, 53 (06): : 278 - 283
  • [48] Next-Generation Sequencing Demands Next-Generation Phenotyping
    Hennekam, Raoul C. M.
    Biesecker, Leslie G.
    HUMAN MUTATION, 2012, 33 (05) : 884 - 886
  • [49] Assessing the Value of Next-Generation Sequencing Technologies: An Introduction
    Phillips, Kathryn A.
    VALUE IN HEALTH, 2018, 21 (09) : 1031 - 1032
  • [50] Next-generation sequencing
    Haferlach, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 40 - 41